Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis

Otolaryngology - Head and Neck Surgery

Volumn 146, Issue 1, 2012, Pages 40-45

  Azuma, Takahiro ^a   Nakamura, Katsuhiko ^a   Takahashi, Mika ^a   Ohyama, Seizo ^b   Toda, Naoki ^b   Iwasaki, Hidetaka ^c   Kalubi, Bukasa ^a   Takeda, Noriaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c TOKUSHIMA RED CROSS HOSPITAL   (Japan)

Author keywords

Biofeedback rehabilitation; Botulinum toxin; Facial synkinesis

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; AGED; ARTICLE; BELL PALSY; CLINICAL ARTICLE; EYE OPENING; FACIAL NERVE PARALYSIS; FACIAL SYNKINESIS; FEEDBACK SYSTEM; FEMALE; HUMAN; MALE; MOUTH MOVEMENT; MOVEMENT (PHYSIOLOGY); REHABILITATION CARE; SYNKINESIS; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; FACE; FACE MUSCLE; FOLLOW UP; INTRAMUSCULAR DRUG ADMINISTRATION; MIDDLE AGED; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOPHYSIOLOGY; TREATMENT OUTCOME;

ADULT; AGED; BIOFEEDBACK, PSYCHOLOGY; BOTULINUM TOXINS, TYPE A; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FACE; FACIAL MUSCLES; FACIAL PARALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MUSCLE CONTRACTION; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; SYNKINESIS; TREATMENT OUTCOME;

EID: 84857159013     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599811424125     Document Type: Article

References (13)

1. Hussenman J, Mehta RP. Management of synkinesis. Facial Plast Surg. 2008;24:242-249. (Pubitemid 351717357)
2. May M. Management of facial hyperkinesis: overview of hyperkinesis. In: May M, Schaitkin B, eds. The Facial Nerve. New York: Thieme; 2000:431-439.
3. Ross B, Nedzelski JM, McLean JA. Efficacy of feedback training in long-standing facial nerve paralysis. Laryngoscope. 1991;101:774-750.
4. Nakamura K, Toda N, Sakamaki K, et al. Biofeedback rehabilitation for prevention of synkinesis after facial palsy. Otolaryngol Head Neck Surg. 2003;128:539-543. (Pubitemid 36438430)
5. Armstrong MWJ, Mountain RE, Murray JAM. Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy. Clin Otolaryngol. 1996;21:15-20. (Pubitemid 26070326)
6. Borodic G, Bartley M, Slattery W, et al. Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints. Plast Reconstr Surg. 2005;116:36-43. (Pubitemid 40944016)
7. Ito H, Nakano S, Kusaka H. Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation. Acta Neurol Scand. 2007;115:271-274. (Pubitemid 46449583)
8. Toffola ED, Furini F, Redaelli C, Prestifilippo E, Bejor M. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Disabil Rehabil. 2010;32:1414-1418.
9. Comella JX, Molgo J, Faille L. Sprouting of mammalian motor nerve terminal induced by in vivo injection of botulinum type-D toxin and the functional recovery of paralyzed neuromuscular junctions. Neurosci Lett. 1993;153:61-64. (Pubitemid 23147037)
10. Eleopra R, Tignoli V, De Grandis D. The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans. Mov Disord. 1997;12:89-94. (Pubitemid 27032885)
11. Segal B, Hunter T, Danys I, Freedman C, Black M. Minimizing synkinesis during rehabilitation of the paralyzed face: preliminary assessment of a new small-movement therapy. J Otolaryngol. 1995;24:149-153.
12. Brach JS, VanSwearingen JM, Lenert J, Johnson PC. Facial neuromuscular retraining for oral synkinesis. Plast Reconstr Surg. 1997;99:1922-1931.
13. Dalla Toffola E, Bossi D, Buonocore M, et al. Usefulness of BFB/EMG in facial palsy rehabilitation. Disabil Rehabil. 2005;27:809-815. (Pubitemid 41015520)